S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
CNSX:PMC

Pharmerica Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume13,000 shs
Average Volume5,703 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive PMC News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharmerica and its competitors with MarketBeat's FREE daily newsletter.


About Pharmerica

Peloton Minerals Corporation, a mineral exploration company, acquires and explores for mineral properties in Canada and the United States. The company primarily explores for gold and silver deposits. It principally owns three gold exploration projects located in Elko County, Nevada; and one gold exploration project in Montana, the United States. The company was formerly known as Montana Gold Mining Company Inc. and changed its name to Peloton Minerals Corporation in 2016. Peloton Minerals Corporation was incorporated in 2000 and is headquartered in London, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Gold
Sub-Industry
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Pharmerica (CNSX:PMC) Frequently Asked Questions

What stocks does MarketBeat like better than Pharmerica?

Wall Street analysts have given Pharmerica a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Pharmerica wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Pharmerica's key executives?

Pharmerica's management team includes the following people:
  • Mr. Edward L. Ellwood M.B.A., MBA, Pres, CEO & Director (Age 61, Pay $120k)
  • Mr. Eric J. Plexman, Corp. Sec., CFO & Director (Age 68, Pay $65k)
  • Mr. Richard Crissman Capps Ph.D., Independent Sr. Geologist & Director
  • Mr. Paul V. Teodorovici, Exec. VP & Director
  • Mr. Paul Strobel, VP of Marketing & Bus. Devel. (Age 74)

What other stocks do shareholders of Pharmerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmerica investors own include Enbridge (ENB), Delta Air Lines (DAL), Air Canada (AC), TELUS (T), Fortis (FTS), Ford Motor (F), Enterprise Products Partners (EPD), Capital Power (CPX), Bank of America (BAC) and The Boeing (BA).

What is Pharmerica's stock symbol?

Pharmerica trades on the CNSX under the ticker symbol "PMC."

How do I buy shares of Pharmerica?

Shares of PMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharmerica's official website?

The official website for Pharmerica is www.pharmerica.com.

How can I contact Pharmerica?

The company can be reached via phone at 519-964-2836.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.